Summary

US Glucose Biosensors Market is valued approximately at USD 3.06 billion in 2023 and is anticipated to grow with a growth rate of more than 8.18% over the forecast period 2024-2032. Glucose biosensors are analytical devices used to measure glucose concentrations in various samples, such as blood. They consist of a biological sensing element, usually an enzyme like glucose oxidase, which specifically interacts with glucose. This interaction produces a signal, often electrical, which is proportional to the glucose concentration. These devices are crucial in managing diabetes by enabling continuous monitoring of blood glucose levels, thus helping to maintain optimal glucose control and prevent complications associated with the disease. Glucose biosensors have evolved to become highly accurate, user-friendly, and accessible for personal and clinical use. Furthermore, rising innovations in biosensor technology, including the development of non-invasive and minimally invasive sensors are gaining attention towards US Glucose Biosensors Market.

The US Glucose Biosensors Market is driven by rising prevalence of diabetes in the country is a significant driver. With an increasing number of individuals diagnosed with diabetes, there is a growing demand for glucose monitoring devices to manage the condition effectively. Additionally, technological advancements in glucose biosensors have enhanced their accuracy, convenience, and user-friendliness, further fueling market growth. Moreover, the shift towards personalized healthcare and the emphasis on preventive care are encouraging individuals to monitor their glucose levels regularly, thereby boosting the adoption of glucose biosensors. Furthermore, supportive government initiatives and reimbursement policies for diabetes management devices are also contributing to market expansion. However, high spending associated with development of Glucose Biosensors is going to impede the overall demand for the market during the forecast period 2024-2032.


Major market player included in this report are:
Abbott Laboratories
Dexcom Inc
Medtronic Inc
Glysens Incorporated
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Type
Electrochemical Biosensor
Optical Biosensor
Others

By End Use
Hospitals
Homecare
Diagnostic Center


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Glucose Biosensors Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Glucose Biosensors Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Type
2.2.2. By End Use
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Glucose Biosensors Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Glucose Biosensors Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Glucose Biosensors Market Size & Forecasts by Type 2022-2032
5.1. Electrochemical Biosensor
5.2. Optical Biosensor
5.3. Others
Chapter 6. US Glucose Biosensors Market Size & Forecasts by End Use 2022-2032
6.1. Hospitals
6.2. Homecare
6.3. Diagnostic Center
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Abbott Laboratories
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Dexcom Inc
7.3.3. Medtronic Inc
7.3.4. Glysens Incorporated
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes